An update on drug–drug interactions between antiretroviral therapies and drugs of abuse in HIV systems
Abstract
Introduction: While considerable progress has been made in the fight against HIV/AIDS, to date there has not been a cure, and millions of people around the world are currently living with HIV/AIDS. People living with HIV/AIDS have substance abuse disorders at higher rates than non-infected individuals, which puts them at an increased risk of drug–drug interactions. Areas covered: Potential drug–drug interactions are reviewed for a variety of potential drugs of abuse, both licit and illicit. These drugs include alcohol, cigarettes or other nicotine delivery systems, methamphetamine, cocaine, opioids, and marijuana. Potential interactions include decreased adherence, modulation of drug transporters, or modulation of metabolic enzymes. We also review the relative incidence of the use of these drugs of abuse in People living with HIV/AIDS. Expert opinion: Despite considerable improvements in outcomes, disparities in outcomes between PLWHA who use drugs of abuse, vs those who do not still exist. It is of critical necessity to improve outcomes in these patients and to work with them to stop abusing drugs of abuse.
Publication Title
Expert Opinion on Drug Metabolism and Toxicology
Recommended Citation
Desai, N., Burns, L., Gong, Y., Zhi, K., Kumar, A., Summers, N., Kumar, S., & Cory, T. (2020). An update on drug–drug interactions between antiretroviral therapies and drugs of abuse in HIV systems. Expert Opinion on Drug Metabolism and Toxicology, 16 (11), 1005-1018. https://doi.org/10.1080/17425255.2020.1814737
